Guatemala is the production and distribution center of many global pharmaceutical companies for Central America and the Caribbean markets.
Owning the largest market in the region it is also the leading manufacturer and exporter.
The experience of more than 4,000 clinical trials for the world’s largest pharmaceutical companies conducted in our research centers.
All of this makes Guatemala the best investment destination of all Central America and the Caribbean.
Exports to various destinations mainly Central America, the United States and Europe, reached a value of USD 362 million during 2022, led by therapeutic products and otc
The pharmaceutical market in Guatemala has a value of USD 2.059 billion in 2022, leading the region accounting 36% of the total share
The largest network of medical professionals in the whole region, all specialties in cutting edge hospitals and clinics. Plastic Surgery, Traumatology, Orthodontics, Hair and Dermatology and Bariatric surgery among others.
More than 4000 clinical trials have been runned successfully in guatemalan research centers from phase 2, phase 3 in various pathologies for the most important developers
Guatemala is the main exporter of rubber in Latin America above countries such as Brazil and Mexico and is one of the largest producers worldwide, manufacturing industry of medical inputs such as latex gloves, catheters, condoms among others. They find great opportunities to secure supply to North American markets in a few days, optimizing their production and reducing costs
Pharmaceutical, medical-chemical, and botanical products manufactured for pharmaceutical use reached USD 531 million1 in 2018, according to Bank of Guatemala (Central Bank).
This industry generated a total of 5,892 direct jobs and 60,000 indirect jobs in 20182 , which constituted USD 86 million in annual salaries.
© Guatemala Moving Forward – 2024. All rights reserved. Privacy Policy
